Schedule 13G ownership disclosure
Immunic Inc
common stock · CUSIP: 4525EP101
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Aberdeen Group plc
Shares: 8,243,941.00 · Class: 8.603%
- abrdn Inc
Shares: 8,243,941.00 · Class: 8.603%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-004384
- Form type
- SCHEDULE 13G
- Filer
- Aberdeen Group plc
- CIK
- CIK 1716774
- Filed
- Jul 31, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership